Logo
x

Search category

Subscribe Now

Actuate Therapeuticsm

Actuate Therapeutics Initiates Randomized Trial of Elraglusib + Folfirinox as 1L Treatment of Advanced Pancreatic Cancer

Actuate Therapeutics Initiates Randomized Trial of Elraglusib + Folfirinox as 1L Treatment of Advanced Pancreatic Cancer

  • February 8, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.